Position in JNJ
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$14,536,734
-$134,554 QoQ
Shares Held
57,238
-4.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.89%
of 13F equity value
Holder Rank
#904
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sowell Financial Services LLC holds $62,788,240 across 14 Drug Manufacturers - General names. JNJ ranks #1 (23.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
57,238 | $14,536,734 | |
| 2 | ABBV |
AbbVie Inc.
|
44,316 | $11,151,678 | |
| 3 | MRK |
Merck & Co., Inc.
|
75,015 | $9,639,427 | |
| 4 | LLY |
ELI LILLY & Co
|
7,621 | $9,140,856 | |
| 5 | PFE |
Pfizer Inc
|
185,807 | $4,474,232 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
68,220 | $3,930,836 | |
| 7 | AMGN |
Amgen Inc
|
10,762 | $3,897,135 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
15,103 | $1,908,113 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,536,734 | 57,238 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $14,671,288 | 60,020 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $12,416,172 | 59,996 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $11,024,146 | 59,455 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $9,199,674 | 60,227 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $9,763,000 | 58,870 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $8,395,914 | 58,055 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $9,512,759 | 58,699 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $8,209,222 | 56,166 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $9,101,619 | 57,536 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $9,513,491 | 60,696 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $9,610,865 | 61,707 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $13,010,699 | 78,605 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $8,626,835 | 55,657 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $13,532,096 | 76,604 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $11,426,541 | 69,947 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $12,310,318 | 69,350 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,808,741 | 15,848 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $11,244,088 | 65,728 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $10,970,695 | 67,930 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $10,231,836 | 62,109 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $15,945,565 | 97,022 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $13,975,658 | 88,802 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $13,078,065 | 87,843 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $11,401,858 | 81,077 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $10,345,894 | 78,898 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||